In summary, our results provide new insights into the anti-tumor mechanisms of SGR, which plays an anti-tumor role by reversing the polarization of tumor-associated M1 to M2 macrophages and promoting the recruitment of CD4+ and CD8+ T cells in TAMs. The gene discussed is CD8A; the disease is neoplasm.